ArticleJournal of cellular and molecular medicine2020

Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells.

Chen Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.